Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to secrete more insulin and curbing glucagon https://arrankfpe110213.ka-blogs.com/88926257/grasping-semaglutide-a-comprehensive-guide